Fatty liver disease is not just a liver problem: how gut microbes, genes and metabolism collide
A new review explains how gut microbes, host genetics and metabolic dysfunction interact to drive MASLD and shape emerging therapies.
A new review explains how gut microbes, host genetics and metabolic dysfunction interact to drive MASLD and shape emerging therapies.
An international expert panel calls for MASLD to be managed as a systemic cardiometabolic disease, proposing bidirectional heart–liver screening, fibrosis-based ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine